Siemens, Gamma Medica end SPECT, SPECT-CT partnership

TriMed Staff | | Health Imaging | Diagnostic Imaging
Siemens Medical Solutions and Gamma Medica Inc. this week announced that they will not renew their worldwide marketing agreement which included exclusive marketing rights for Siemens to market Gamma Medica's pre-clinical SPECT and SPECT/CT imaging products, according to a joint release.
   
Gamma Medica CEO Bradley Patt, PhD, indicated that though the market is expanding rapidly, the company's agreement had to be ended because of Siemens' impending purchase of CTI and also because of the existing overlap between the two companies' pre-clinical products, the companies said.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.